Treatment of Chronic Itch in Atopic Dermatitis (Eczema)
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of oral clonidine in subjects
with symptomatic atopic dermatitis and to assess the safety and efficacy of oral naltrexone
in subjects with symptomatic atopic dermatitis.
Phase:
Phase 1
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute